Literature DB >> 23493636

Non-steroidal anti-inflammatory drugs in colorectal surgery: A risk factor for anastomotic complications?

Jörgen Rutegård1, Martin Rutegård.   

Abstract

In a recent article, Gorissen et al report on 795 patients with primary colorectal anastomosis operated on during the period 2008-2010 for different colorectal conditions at two centres. The leakage rate was significantly higher among patients who were administered non-steroidal anti-inflammatory drugs (NSAIDs) in the perioperative course. A dose-response relationship could also be traced, where longer NSAID use yielded a higher risk of anastomotic breakdown. However, as this study is observational in design, confounding by indication may be present and there is also a risk of residual confounding from unmeasured covariates. Moreover, the question whether different affinity for the cyclooxygenase enzyme is important in different NSAIDs seems to be largely unanswered. The results, conclusions and clinical relevance of the aforementioned study, including the possible effects of different types of NSAIDs, are discussed. While acknowledging that this study represents the best attempt so far in establishing the causal relationship between perioperative NSAID use and anastomotic leakage, the need for further research in this important area is underlined.

Entities:  

Keywords:  Anastomotic leak; Cancer; Colon; Leakage; Non-steroidal anti-inflammatory drugs; Rectum

Year:  2012        PMID: 23493636      PMCID: PMC3596523          DOI: 10.4240/wjgs.v4.i12.278

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  18 in total

1.  Volume-outcome analysis of colorectal cancer-related outcomes.

Authors:  D W Borowski; D M Bradburn; S J Mills; B Bharathan; R G Wilson; A A Ratcliffe; S B Kelly
Journal:  Br J Surg       Date:  2010-09       Impact factor: 6.939

2.  Postoperative opioid sparing to hasten recovery: what are the issues?

Authors:  Henrik Kehlet
Journal:  Anesthesiology       Date:  2005-06       Impact factor: 7.892

3.  Severe complications with diclofenac after colonic resection.

Authors:  Jacob Rosenberg; Thomas Harvald
Journal:  Dis Colon Rectum       Date:  2007-05       Impact factor: 4.585

Review 4.  Colonic anastomotic leak: risk factors, diagnosis, and treatment.

Authors:  T Peter Kingham; H Leon Pachter
Journal:  J Am Coll Surg       Date:  2008-12-04       Impact factor: 6.113

5.  Increased risk of anastomotic leakage with diclofenac treatment after laparoscopic colorectal surgery.

Authors:  Mads Klein; Lars Peter Holst Andersen; Thomas Harvald; Jacob Rosenberg; Ismail Gogenur
Journal:  Dig Surg       Date:  2009-01-20       Impact factor: 2.588

6.  Anastomotic leakage after resection of colorectal cancer generates prodigious use of hospital resources.

Authors:  J Frye; E L Bokey; P H Chapuis; G Sinclair; O F Dent
Journal:  Colorectal Dis       Date:  2008-10-28       Impact factor: 3.788

7.  Effect of diclofenac on cyclooxygenase-2 levels and early breaking strength of experimental colonic anastomoses and skin incisions.

Authors:  M Klein; P-M Krarup; J Burcharth; M S Ågren; I Gögenur; L N Jorgensen; J Rosenberg
Journal:  Eur Surg Res       Date:  2010-12-07       Impact factor: 1.745

8.  Risk factors for anastomotic leakage after anterior resection of the rectum.

Authors:  P Matthiessen; O Hallböök; M Andersson; J Rutegård; R Sjödahl
Journal:  Colorectal Dis       Date:  2004-11       Impact factor: 3.788

9.  Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.

Authors:  Wai Lun Law; Kin Wah Chu
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

10.  Cyclo-oxygenase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery.

Authors:  K Holte; J Andersen; D Hjort Jakobsen; H Kehlet
Journal:  Br J Surg       Date:  2009-06       Impact factor: 6.939

View more
  2 in total

1.  Effect of Perioperative Dexamethasone and Different NSAIDs on Anastomotic Leak Risk: A Propensity Score Analysis.

Authors:  Christian Fredrik Rushfeldt; Uwe Conrad Agledahl; Baldur Sveinbjørnsson; Kjetil Søreide; Tom Wilsgaard
Journal:  World J Surg       Date:  2016-11       Impact factor: 3.352

2.  Total Flavonoids from Radix Glycyrrhiza Exert Anti-Inflammatory and Antitumorigenic Effects by Inactivating iNOS Signaling Pathways.

Authors:  Yi-Xin Jiang; Yang-Yi Dai; Yi-Feng Pan; Xi-Min Wu; Yue Yang; Ka Bian; Dan-Dan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-22       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.